Ada Girnita

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

INDIVIDUAL ARTICLE: NECOM 7: Real-World Cases on Preventive and Treatment Using Skin Care for Cancer Treatment-Related Skin Reactions.

INDIVIDUAL ARTICLE: NECOM 7: Real-World Cases on Preventive and Treatment Using Skin Care for Cancer Treatment-Related Skin Reactions.

Journal: Journal of drugs in dermatology : JDD

Published: December 02, 2025

INDIVIDUAL ARTICLE: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy.

INDIVIDUAL ARTICLE: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy.

Journal: Journal of drugs in dermatology : JDD

Published: May 06, 2025

INDIVIDUAL ARTICLE: NECOM 5: Algorithm for the Treatment and Supportive Management of Targeted Therapy-Related Cutaneous Adverse Events.

INDIVIDUAL ARTICLE: NECOM 5: Algorithm for the Treatment and Supportive Management of Targeted Therapy-Related Cutaneous Adverse Events.

Journal: Journal of drugs in dermatology : JDD

Published: March 05, 2025

Correction: Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.

Correction: Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.

Journal: Oncogene

Published: September 09, 2024

INDIVIDUAL ARTICLE: NECOM 4: Algorithm Integrating Skincare for the Management of Immunotherapy-Related Cutaneous Adverse Events for Cancer Patients and Survivors.

INDIVIDUAL ARTICLE: NECOM 4: Algorithm Integrating Skincare for the Management of Immunotherapy-Related Cutaneous Adverse Events for Cancer Patients and Survivors.

Journal: Journal of drugs in dermatology : JDD

Published: August 02, 2024

INDIVIDUAL ARTICLE: NECOM 3: A Practical Algorithm for the Management of Radiation Therapy-Related Acute Radiation Dermatitis.

INDIVIDUAL ARTICLE: NECOM 3: A Practical Algorithm for the Management of Radiation Therapy-Related Acute Radiation Dermatitis.

Journal: Journal of drugs in dermatology : JDD

Published: November 09, 2023

Nevus-associated Lentigo Maligna and Lentigo Maligna Melanoma, Clinicopathological Features.

Nevus-associated Lentigo Maligna and Lentigo Maligna Melanoma, Clinicopathological Features.

Journal: Acta dermato-venereologica

Published: August 09, 2023

Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma.

Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma.

Journal: Oncogene

Published: February 09, 2023

Supplement Individual Article: NECOM Skincare Algorithm for Patients With Cancer and Survivors.

Supplement Individual Article: NECOM Skincare Algorithm for Patients With Cancer and Survivors.

Journal: Journal of drugs in dermatology : JDD

Published: January 06, 2023

Correction: The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway.

Correction: The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway.

Journal: Oncogene

Published: December 16, 2022

Retraction Note: Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.

Retraction Note: Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.

Journal: Oncogene

Published: December 09, 2022

Correction: Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1.

Correction: Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1.

Journal: Oncogene

Published: December 08, 2022

Showing 1-12 of 42

Last Updated: 09/26/2026